Гематология
1411 статей · 38 журналов
Динамика публикаций
Журналы подкатегории (38)
- Annals of Thoracic Surgery Short Reports · Elsevier (89)
- Blood Advances · Elsevier (89)
- Journal of Thrombosis and Haemostasis · Elsevier (85)
- Research and Practice in Thrombosis and Haemostasis · Elsevier (80)
- Thrombosis Research · Elsevier (80)
- British Journal of Haematology · Wiley (75)
- European Journal of Haematology · Wiley (74)
- Clinical Lymphoma, Myeloma & Leukemia · Elsevier (71)
- Transfusion and Apheresis Science · Elsevier (69)
- Radiotherapy & Oncology · Elsevier (66)
- Blood · Elsevier (65)
- Vox Sanguinis · Wiley (65)
- Annals of Oncology · Elsevier (62)
- American Journal of Hematology · Wiley (58)
- Haemophilia · Wiley (58)
- Hematology/Oncology Clinics of North America · Elsevier (50)
- Transfusion · Wiley (49)
- Transfusion Medicine Reviews · Elsevier (39)
- Seminars in Hematology · Elsevier (37)
- The Lancet Haematology · Elsevier (28)
- Seminars in Oncology · Elsevier (27)
- Experimental Hematology · Elsevier (21)
- HemaSphere · Wiley (17)
- Thrombosis Update · Elsevier (14)
- Transfusion Medicine · Wiley (13)
- Journal of Clinical Apheresis · Wiley (12)
- Blood Cancer Journal · Springer Nature (7)
- Leukemia · Springer Nature (7)
- Ca-A Cancer Journal for Clinicians · Wiley (4)
- Annals of Hematology · Springer Nature (0)
- Blood Research · Springer Nature (0)
- Experimental Hematology & Oncology · Springer Nature (0)
- Indian Journal of Hematology and Blood Transfusion · Springer Nature (0)
- International Journal of Clinical Oncology · Springer Nature (0)
- International Journal of Hematology · Springer Nature (0)
- Medical Oncology · Springer Nature (0)
- Thrombosis Journal · Springer Nature (0)
- memo - Magazine of European Medical Oncology · Springer Nature (0)
- Thalassaemia revisited: whose progress?
- Bridging the thalassaemia divide in south and southeast Asia
- α-thalassaemia: an overlooked disease entering a new era
- Hydroxyurea benefits for sickle cell anaemia in sub-Saharan Africa
- Rethinking anti-BCMA T-cell engager design
- Improved survival after allo-HCT in Hodgkin lymphoma: true progress or time-dependent confounding?
- Improved survival after allo-HCT in Hodgkin lymphoma: true progress or time-dependent confounding? – Authors’ reply
- Should plasma cell leukaemia be classified as multiple myeloma?
- Incidence of clinically diagnosed infections in children with sickle cell anaemia treated with oral hydroxyurea in Angola, DR Congo, Kenya, and Uganda: a retrospective cohort study from the REACH trial
- Phenotype, treatment, and determinants of prognosis in Erdheim–Chester disease: an international, retrospective, cohort study
- Decitabine plus busulfan–cyclophosphamide versus busulfan–cyclophosphamide myeloablative conditioning before allogeneic haematopoietic stem cell transplantation for reducing risk of relapse in adult KMT2A‑rearranged leukaemia in China: an open-label, multicentre, randomised phase 3 trial
- MK-4002, a B-cell maturation antigen-targeting T-cell engager, in relapsed or refractory multiple myeloma: a first-in-human, open-label, phase 1 study
- The expanding therapeutic landscape of β-thalassaemia
- Future-proofing thalassaemia care: harnessing scalable therapies, artificial intelligence, and global collaboration
- Emerging novel therapies for the treatment of hereditary haemorrhagic telangiectasia
- Rethinking the possibilities of adult ring sideroblastic anaemia
- Amrecibart and cenvacibart for the prevention of catheter-related thrombosis (ROXI-CATH): a double-blind, randomised, placebo-controlled, phase 2 trial
- Plasma lipid species and breast cancer phenotypes: a two-sample Mendelian randomization analysis with multiplicity and sensitivity assessment
- Interplay of Oncogenic Pathways in Colorectal Cancer: Mechanisms Driving Progression and Drug Resistance
- Masthead
- Editorial Board
- Table of Contents
- Tumour immunotherapy in solid and hematologic malignancies: Progress, challenges, and a practical framework
- Single-cell sequencing in pan-cancer research: Decoding heterogeneity, tumor microenvironment, and clinical translation
- Integrating patient-reported outcomes into explainable machine learning models for long-term survival prediction in TKI-treated metastatic renal cell carcinoma
- The role of fumarate and itaconate in tumor microenvironment
- Spatiotemporal decoding of the pre-metastatic niche: Multi-omics innovations and clinical horizons
- SPIB as a context–specific regulator in cancer: from molecular mechanisms to clinical implications
- Bone metastasis in cancer: from microenvironmental remodeling to precision therapy
- Microbiome oncolytic virus interactions in cancer: emerging evidence and therapeutic implications for immunotherapy